Clinical Trial: A Phase 1, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of ETH47 in Healthy Participants

U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07055321) titled 'A Phase 1, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of ETH47 in Healthy Participants' on June 27.

Brief Summary: This first-in-human study is designed to evaluate the safety, tolerability, pharmacokinetics and target engagement of ETH47 in healthy participants following single intranasal and single inhaled administration

Study Start Date: Nov. 29, 2023

Study Type: INTERVENTIONAL

Condition: Healthy Subjects

Intervention: DRUG: ETH47

Dose level 1; single intranasal administration

DRUG: ETH47

Dose level 2; single intranasal administration

DRUG: E...